SCAI Urges CMS to Reconsider Decision on Carotid Artery Stenting

www.prnewswire.com

This week's decision means CMS will make no changes to its current coverage restrictions. In making its decision, CMS cited a lack of published data on the benefits of CAS.

http://www.prnewswire.com/cgi-bin/stories.pl?ACCT=109&STORY=/www/story/10-16-2008/0004905710&EDATE=

PMA Final Decisions for February 2008

www.fda.gov | Mar 19, 2008

Some of the documents on this section of the CDRH Website are available only in PDF format and may not be accessible to those with certain disabilities. If you cannot access the documents you are interested in, please use the accessibility link for assistance.

http://www.fda.gov/cdrh/pma/pmafeb08.html

t. Jude Medical's Proxis Embolic Protection System Gets FDA Approval

The Proxis Embolic Protection System is the first FDA cleared embolic protection system to provide protection proximally, or “upstream,” from an SVG blockage.

http://www.compliancehome.com/news/FDA/11112.html

Abbott Announces European Launch of Next-generation Device Designed to Treat Patients at Risk of

The Emboshield PRO Embolic Protection System is designed to be more radiopaque than its predecessor, the Emboshield Embolic Protection System, providing better visibility during X-ray angiography.

http://www.abbott.com/global/url/pressRelease/en_US/60.5:5/Press_Release_0352.htm

The Vertical Group - News Releases

Velocimed® Announces Closing of Series D Financing and Significant Milestones Achieved for the Proxis®, Premere and Venture Products Minneapolis, MN, September 21, 2004 - Velocimed LLC.

http://www.vertical-group.com/news-092104.htm

The Journal of Invasive Cardiology

Case Report. The patient was a 76-year-old male with the cardiovascular risk factors of hypertension and hyperlipidemia. His cardiovascular history began in April 2000, with a myocardial infraction (MI) of the anteroseptal wall; although, he was managed conservatively.

http://www.invasivecardiology.com/article/2532

Medtech Insight, LLC - News

- November 17, 2004: Stroke a sudden and often catastrophic disruption in the delivery of oxygen and nutrients to the tissues of the brain is the third-leading cause of death in the U.S.

http://www.medtechinsight.com/newsroom/news111704.html

Pharmacy Choice - Pharmaceutical News - Clinical Trial Demonstrates Positive Results for St. Jude

WASHINGTON--(BUSINESS WIRE)--Oct. 18, 2005--Data from a key clinical trial show that a new embolic protection device from St. Jude Medical, Inc. (NYSE:STJ) has demonstrated positive results for treating patients with saphenous vein coronary bypass grafts.

http://www.pharmacychoice.com/News/article.cfm?Article_ID=15045